Evaluation of Digital Mental Health Technologies in the United States: Systematic Literature Review and Framework Synthesis

Author:

Catania JuliannaORCID,Beaver StephORCID,Kamath Rakshitha SORCID,Worthington EmmaORCID,Lu MinyiORCID,Gandhi HemaORCID,Waters Heidi CORCID,Malone Daniel CORCID

Abstract

Background Digital mental health technologies (DMHTs) have the potential to enhance mental health care delivery. However, there is little information on how DMHTs are evaluated and what factors influence their use. Objective A systematic literature review was conducted to understand how DMHTs are valued in the United States from user, payer, and employer perspectives. Methods Articles published after 2017 were identified from MEDLINE, Embase, PsycINFO, Cochrane Library, the Health Technology Assessment Database, and digital and mental health congresses. Each article was evaluated by 2 independent reviewers to identify US studies reporting on factors considered in the evaluation of DMHTs targeting mental health, Alzheimer disease, epilepsy, autism spectrum disorder, or attention-deficit/hyperactivity disorder. Study quality was assessed using the Critical Appraisal Skills Program Qualitative and Cohort Studies Checklists. Studies were coded and indexed using the American Psychiatric Association’s Mental Health App Evaluation Framework to extract and synthesize relevant information, and novel themes were added iteratively as identified. Results Of the 4353 articles screened, data from 26 unique studies from patient, caregiver, and health care provider perspectives were included. Engagement style was the most reported theme (23/26, 88%), with users valuing DMHT usability, particularly alignment with therapeutic goals through features including anxiety management tools. Key barriers to DMHT use included limited internet access, poor technical literacy, and privacy concerns. Novel findings included the discreetness of DMHTs to avoid stigma. Conclusions Usability, cost, accessibility, technical considerations, and alignment with therapeutic goals are important to users, although DMHT valuation varies across individuals. DMHT apps should be developed and selected with specific user needs in mind.

Publisher

JMIR Publications Inc.

Reference51 articles.

1. Content of premarket submissions for device software functions: guidance for industry and Food and Drug Administration staffU.S. Food and Drug Administration20236142024-07-19https://www.fda.gov/media/153781/download

2. Characteristics and challenges of the clinical pipeline of digital therapeutics

3. Policy for device software functions and mobile medical applications: guidance for industry and Food and Drug Administration staffU.S. Food and Drug Administration2023-01-06https://www.fda.gov/media/80958/download

4. Smartphone Apps for College Mental Health: A Concern for Privacy and Quality of Current Offerings

5. Augmenting Mental Health in Primary Care: A 1-Year Study of Deploying Smartphone Apps in a Multi-site Primary Care/Behavioral Health Integration Program

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3